Alzheimer's Disease Clinical Trials in Los Angeles

Showing 201-220 of 247 trials

TERMINATEDEARLY Phase 1< 1 mile

A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808

NCT01723488

\[F-18\]T808 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.

Alzheimers Disease

Avid Radiopharmaceuticals12 participantsStarted Jul 2012

Irvine, California, United States • Los Angeles, California, United States

TERMINATEDEARLY Phase 1< 1 mile

A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807

NCT01733355

\[F-18\]T807 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.

Alzheimers DiseaseAD

Avid Radiopharmaceuticals11 participantsStarted Jul 2012

Irvine, California, United States • Los Angeles, California, United States

COMPLETED< 1 mile

Memory Disorders Registry

NCT00654563

The study is designed to collect data regarding the clinical course and outcome of patients suffering from memory disorders. Visits are charged to the individual's insurance inclusive of Medicare. Patients benefit from expert evaluation and treatment recommendations. Participants may be eligible for participation in experimental treatments in the future.

DementiaAlzheimer's DiseaseParkinson Disease+1 more

Cedars-Sinai Medical Center12 participantsStarted Aug 2007

Los Angeles, California, United States

UNKNOWN< 1 mile

Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls

NCT01147679

This study is designed to document the loss of sociomoral emotions (like empathy, guilt, and embarrassment) in patients with behavioral variant frontotemporal dementia. The loss of these emotions, which function as the motivators for social behavior, will manifest in specific interpersonal behaviors. These behaviors will correlate with regional changes in regional changes in medial frontal and anterior temporal lobes. These social and emotional changes will be compared with a young-onset Alzheimer's disease comparison group.

Frontotemporal DementiaFrontotemporal DegenerationAlzheimer's Disease+1 more

University of California, Los Angeles99 participantsStarted Jan 2010

Los Angeles, California, United States

A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808

A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807

Memory Disorders Registry

Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls

Alzheimer's Disease Trials in Other Cities

Building Better Caregivers Online: An Online Workshop for Caregivers of Those With Traumatic Brain Injury, Post Traumatic Stress Disorder, or Alzheimer's or Other Dementia

Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome

A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease

A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects

Multiple Dose Japanese Bridging Study

A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44

A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease

An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain

Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

Other Conditions in Los Angeles